advertise   
Home > Featured Videos > FDA Warnings
Featured Videos

Search Results For "FDA Warnings"



From: Dean Heller, MD Category: FDA Warnings
City: Miami Language: English

FDA warning on haloperidol, or haldol and the risk of heart arrhythmias.



From: Randy Miller, MD Category: FDA Warnings
City: Miami Language: English

The FDA issued and early communication on adverse events from Botox and Myobloc. These were mostly from off label uses of the medications, and this is an early communication.



From: Rodrigo Duarte, rn Category: FDA Warnings
City:  - Language: English

Gadolinium, which is commonly used during an MRI as a contrast agent, have a new FDA warning that they can cause NSF/NFD, nephrogenic systemic Fibrosis/Nephrogenic Fibrosing Dermopathy. These are diseases which cause fibrosis of the skin and internal organs. These problems can occur from a few days to a year after receiving the contrast agent. This videos tell you who is at risk and what the signs are.



From: Ronald Sancetta, MD Category: FDA Warnings
City: Miami Language: English

The FDA reviewed new data on the risk of thromboembolism when certain women use the contraceptive patch.



From: James Krainson, MD Category: FDA Warnings
City: Miami Language: English

The FDA issued a statement on the risk of swallowing the inhaler capsules from inhalers for asthma.



From: jonathan ferreira, mv Category: FDA Warnings
City:  - Language: English

An FDA report on preventing burns from electric dental handpieces.



From: RIchard Kang, MD Category: FDA Warnings
City: Columbus Language: English

The FDA warns about giving young children cough and cold medications



From: Mahmood Pazirandeh, MD, FACP,FACR Category: FDA Warnings
City: Cleveland Language: English

Rituxan is approved for treatment of some other diseases, but not lupus. This FDA warning is for patients with lupus being treated with Rituxan. There is risk of a fatal infection of the brain called PML.



From: Jorge Diego, MD Category: FDA Warnings
City: Miami Language: English

Potentially fatal errors in blood glucose monitering can occur in kidney patients on peritoneal dialysis. If the fluid used for peritoneal dialysis contains Icodextran, this may interfere with your blood glucose monitering system. This video from the FDA reviews the issue.


1 | 2 |
Next>
Search
VideoMD does not provide medical advice, diagnosis or treatment.